logo
搜索
菜单

JoVE Core 视频 在线看

当前20/319页
排序: 本周浏览数
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution 01:17 min
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution
13.10: Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion 01:20 min
13.10: Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
13.6: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism 01:18 min
13.6: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
13.2: Drug Dosing: Obese Patients 01:21 min
13.2: Drug Dosing: Obese Patients
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions 01:26 min
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions
12.17: Pharmacokinetics: Drug–Drug Interactions 01:25 min
12.17: Pharmacokinetics: Drug–Drug Interactions
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules 01:18 min
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
10.6: Drug Dissolution: Requirements and Profile Comparison 01:14 min
10.6: Drug Dissolution: Requirements and Profile Comparison
10.5: In Vitro Drug Dissolution: Alternative Methods 01:17 min
10.5: In Vitro Drug Dissolution: Alternative Methods
9.15: Bioequivalence studies: Biowaivers 01:13 min
9.15: Bioequivalence studies: Biowaivers
9.14: Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs 01:15 min
9.14: Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs 01:20 min
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention 01:05 min
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
9.6: Measurement of Bioavailability: Pharmacokinetic Methods 01:30 min
9.6: Measurement of Bioavailability: Pharmacokinetic Methods
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients 01:15 min
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies 01:11 min
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies
31.26: Disorders of the Male Reproductive System 01:20 min
31.26: Disorders of the Male Reproductive System
12.2: Frost Resistant Concrete 01:29 min
12.2: Frost Resistant Concrete
返回顶部